65 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Dec 2026. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
32
Ending by 2030
Dec 2026
Next term end
20
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Mar 2027 · Low confidence
Also notable
Ends Oct 2030 · Medium confidence
Also notable
Ends Apr 2031 · High confidence
Bronchial Flow Control Devices with Membrane Seal
US 7,798,147
The most cited patent in this portfolio, cited by 364 later US patents, top 1% of utility patents granted in 2010 in our data. Protection runs to 2027. A terminal disclaimer caps this term to an earlier patent's.
Methods and Devices for Passive Residual Lung Volume Reduction and Functional Lung Volume Expansion
US 9,050,094
Cited by 48 later US patents, top 10% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2030.
Lung Volume Reduction Therapy Using Crosslinked Non-Natural Polymers
US 8,198,365
Cited by 63 later US patents, top 10% of utility patents granted in 2012 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2031.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Dec 9 to 11, 2026 · next Dec 9
- 1 fee due Jan 11, 2027The maintenance fee for Collateral Flow Channel Sealant Delivery Methods and Systems (US 11,696,763) comes due Jan 11, 2027. Unpaid by Jul 12, 2027, it lapses early.
- 1 fee due Feb 18, 2027The maintenance fee for Measuring Lung Function and Lung Disease Progression at a Lobar/Segmental Level (US 9,107,606) comes due Feb 18, 2027. Unpaid by Aug 18, 2027, it lapses early.
- 1 fee due Mar 17, 2027The maintenance fee for Collateral Flow Channel Sealant Delivery Methods and Systems (US 10,413,300) comes due Mar 17, 2027. Unpaid by Sep 17, 2027, it lapses early.
- 1 fee due Apr 29, 2027The maintenance fee for Bronchial Sealant Delivery Methods and Systems (US 10,456,562) comes due Apr 29, 2027. Unpaid by Oct 29, 2027, it lapses early.
- 3 fees due May 14 to 21, 2027 · next May 14
- 1 fee due Jun 30, 2027The maintenance fee for Functional Assessment and Treatment Catheters and Methods for Their Use in the Lung (US 10,517,529) comes due Jun 30, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 1 fee due Jul 2, 2027The maintenance fee for High Resistance Implanted Bronchial Isolation Devices and Methods (US 11,857,406) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 1 fee due Aug 27, 2027The maintenance fee for Methods and Systems for Determining Collateral Ventilation (US 11,911,145) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
- 2 fees due Sep 19 to 26, 2027 · next Sep 19
- 1 fee due Oct 28, 2027The maintenance fee for Measuring Lung Function and Lung Disease Progression at a Lobar/Segmental Level (US 10,631,758) comes due Oct 28, 2027. Unpaid by Apr 28, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 19, 2026
What they patent
The 5 largest of its 20 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Bronchial Flow Control Devices with Membrane Seal | 15 in force | to Dec 2030 |
| Methods and Systems for Endobronchial Diagnostics | 5 in force | to May 2034 |
| Methods and Systems for Endobronchial Diagnosis | 5 in force | to Jul 2033 |
| Lung Volume Reduction Therapy Using Crosslinked Non-Natural Polymers | 5 in force | to Apr 2031 |
| Devices and Systems for Lung Treatment | 4 in force | to Apr 2034 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,470,811 | Selective Lung Tissue Ablation In force · Medium confidence | In force | Medium confidence | |
| US 11,304,742 | Selective Lung Tissue Ablation In force · Medium confidence | In force | Medium confidence | |
| US 9,211,181 | Implant Loading Device and System In force · High confidence | In force | High confidence | |
| US 7,798,147 | Bronchial Flow Control Devices with Membrane Seal In force · Low confidence | In force | Low confidence | |
| US 11,298,489 | Methods and Devices for Passive Residual Lung Volume Reduction and Functional Lung Volume Expansion In force · High confidence | In force | High confidence | |
| US 9,486,266 | Selective Lung Tissue Ablation In force · High confidence | In force | High confidence | |
| US 8,206,684 | Methods and Devices for Blocking Flow Through Collateral Pathways in the Lung In force · High confidence | In force | High confidence | |
| US 7,628,789 | Selective Lung Tissue Ablation In force · High confidence | In force | High confidence | |
| US 7,814,912 | Delivery Methods and Devices for Implantable Bronchial Isolation Devices In force · High confidence | In force | High confidence | |
| US 8,445,589 | Lung Volume Reduction Therapy Using Crosslinked Non-Natural Polymers In force · High confidence | In force | High confidence |
Also on record, not counted in the 65: 47 patents ended · 4 applications pending · 60 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.